Teza Capital Management LLC Acquires New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Teza Capital Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,940 shares of the medical equipment provider's stock, valued at approximately $1,013,000.

Several other large investors have also modified their holdings of ISRG. Carnegie Investment Counsel raised its stake in shares of Intuitive Surgical by 33.3% during the 4th quarter. Carnegie Investment Counsel now owns 653 shares of the medical equipment provider's stock worth $341,000 after acquiring an additional 163 shares in the last quarter. Wealthcare Advisory Partners LLC raised its position in Intuitive Surgical by 2.5% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 4,004 shares of the medical equipment provider's stock worth $2,090,000 after acquiring an additional 97 shares during the period. Merit Financial Group LLC raised its position in Intuitive Surgical by 49.7% during the fourth quarter. Merit Financial Group LLC now owns 6,664 shares of the medical equipment provider's stock worth $3,478,000 after acquiring an additional 2,213 shares during the period. Sax Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $328,000. Finally, Sanibel Captiva Trust Company Inc. increased its position in Intuitive Surgical by 46.9% during the fourth quarter. Sanibel Captiva Trust Company Inc. now owns 930 shares of the medical equipment provider's stock worth $485,000 after purchasing an additional 297 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective for the company. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares of the company's stock, valued at $271,397.94. The trade was a 63.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG stock traded down $3.13 during midday trading on Friday, reaching $539.54. 1,138,538 shares of the company were exchanged, compared to its average volume of 1,646,837. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00. The stock's 50-day simple moving average is $511.55 and its 200 day simple moving average is $538.00. The company has a market cap of $193.38 billion, a price-to-earnings ratio of 84.17, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.